Abstract
MUTYH-associated polyposis is an autosomal recessive syndrome predisposing to colorectal cancer. The syndrome was described in the last decade and is characterized by an inherited deficiency in base excision repair. The natural history of the syndrome is still being described. This chapter will address the advances made in MUTYH-associated polyposis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C ® T:A mutations in colorectal tumors. Nat Genet. 2002;30:227–32.
Jones S, Emmerson P, Maynard J, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C ® T:A mutations. Hum Mol Genet. 2002;11:2961–7.
Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med. 2003;348:791–9.
Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 2003;362:39–41.
Leiden open variation database. http://www.LOVD.nl/MUTYH.
Jo W-S, Bandipalliam P, Shannon KM, et al. Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol. 2005;3:1022–8.
Di Gregorio C, Frattini M, Maffei S, et al. Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis. Gastroenterology. 2006;131:439–44.
Halford SE, Rowan AJ, Lipton L, et al. Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol. 2003;162:1545–8.
Enholm S, Hienonen T, Suomalainen A, et al. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol. 2003;163:827–32.
Croitoru ME, Cleary SP, Di Nicola N, et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst. 2004;96:1631–4.
Fleischmann C, Peto J, Cheadle J, et al. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer. 2004;109:554–8.
Gismondi V, Meta M, Bonelli L, et al. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer. 2004;109:680–4.
Isidro G, Laranjeira F, Pires A, et al. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat. 2004;24:353–4.
Kambara T, Whitehall VL, Spring KJ, et al. Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer. 2004;40:1–9.
Vandrovcová J, Štekrová J, Kebrdlová V, et al. Molecular analysis of the APC and MYH genes in Czech families affected by FAP or multiple adenomas: 13 novel mutations. Hum Mutat. 2004;23:397.
Venesio T, Molatore S, Cattaneo F, et al. High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology. 2004;126:1681–5.
Wang L, Baudhuin LM, Boardman LA, et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology. 2004;127:9–16.
Aceto G, Cristina Curia M, Veschi S, et al. Mutations of APC and MYH in unrelated Italian patients with adenomatous polyposis coli. Hum Mutat. 2005;26:394.
Alhopuro P, Parker AR, Lehtonen R, et al. A novel functionally deficient MYH variant in individuals with colorectal adenomatous polyposis. Hum Mutat. 2005;26:393.
Baglioni S, Melean G, Gensini F, et al. A kindred with MYH-associated polyposis and pilomatricomas. Am J Med Genet. 2005;134:212–4.
Eliason K, Hendrickson BC, Judkins T, et al. The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients. J Med Genet. 2005;42:95–6.
Farrington SM, Tenesa A, Barnetson R, et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet. 2005;77:112–9.
Kairupan CF, Meldrum CJ, Crooks R, et al. Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations. Int J Cancer. 2005;116:73–7.
Miyaki M, Iijima T, Yamaguchi T, et al. Germline mutations of the MYH gene in Japanese patients with multiple colorectal adenomas. Mutat Res. 2005;578:430–3.
Nielsen M, Franken PF, Reinards TH, et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet. 2005;42:e54.
Peterlongo P, Mitra N, Chuai S, et al. Colorectal cancer risk in individuals with biallelic or monoallelic mutations of MYH. Int J Cancer. 2005;114:505–7.
Ponti G, Ponz de Leon M, Maffei S, et al. Attenuated familial adenomatous polyposis and Muir–Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet. 2005;68:442–7.
Truta B, Allen BA, Conrad PG, et al. A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history. Fam Cancer. 2005;4:127–33.
Aretz S, Uhlhaas S, Goergens H, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006;119:807–14.
Bai H, Grist S, Gardner J, et al. Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposis. Cancer Lett. 2007;250:74–81.
Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology. 2006;131:30–9.
Colebatch A, Hitchins M, Williams R, et al. The role of MYH and microsatellite instability in the development of sporadic colorectal cancer. Br J Cancer. 2006;95:1239–43.
Kanter-Smoler G, Bjork J, Fritzell K, et al. Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization. Clin Gastroenterol Hepatol. 2006;4:499–506.
Lefevre JH, Rodrigue CM, Mourra N, et al. Implication of MYH in colorectal polyposis. Ann Surg. 2006;244:874–80.
Lejeune S, Guillemot F, Triboulet JP, et al. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Hum Mutat. 2006;27:1064.
Peterlongo P, Mitra N, Mitra N, Sanchez de Abajo A, et al. Increased frequency of disease-causing MYH mutations in colon cancer families. Carcinogenesis. 2006;27:2243–9.
Piccioli P, Serra M, Gismondi V, et al. Multiplex tetra-primer amplification refractory mutation system PCR to detect 6 common germline mutations of the MUTYH gene associated with polyposis and colorectal cancer. Clin Chem. 2006;52:739–43.
Russell AM, Zhang J, Luz J, et al. Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients. Int J Cancer. 2006;118:1937–40.
Webb EL, Rudd MF, Houlston RS. Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet. 2006;79:768–71.
Wynter CVA, Kambara T, Walsh MD, et al. DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients. Int J Cancer. 2006;118:907–15.
van Puijenbroek M, Nielsen M, Reinards THCM, et al. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family. Fam Cancer. 2007;6:43–51.
Balaguer F, Castellvi-Bel S, Castells A, et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol. 2007;5:379–87.
Bouguen G, Manfredi S, Blayau M, et al. Colorectal adenomatous polyposis associated with MYH mutations: genotype and phenotype characteristics. Dis Colon Rectum. 2007;50:1612–7.
Croitoru ME, Cleary SP, Berk T, et al. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients. J Surg Oncol. 2007;95:499–506.
Küry S, Buecher B, Robiou-du-Pont S, et al. The thorough screening of the MUTYH gene in a large French cohort of sporadic colorectal cancers. Genet Test. 2007;11:373–9.
Ponti G, Venesio T, Losi L, et al. BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees. J Invest Dermatol. 2007;127:1387–91.
Å ulová M, ZÃdková K, Kleibl Z, et al. Mutation analysis of the MYH gene in unrelated Czech APC mutation-negative polyposis patients. Eur J Cancer. 2007;43:1617–21.
Vogt S, Jones N, Christian D, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137:1976–85.
Nielsen M, Joerink-Van de Beld MC, Jones N, et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology. 2009;136:471–76.
Yanaru-Fujisawa R, Matsumoto T, Ushijima Y, et al. Genomic and functional analyses of MUTYH in Japanese patients with adenomatous polyposis. Clin Genet. 2008;73:545–53.
Cleary SP, Cotterchio M, Jenkins MA, et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009;136:1251–60.
O’Shea AM, Cleary SP, Croitoru MA, et al. Pathological features of colorectal carcinomas in MYH-associated polyposis. Histopathology. 2008;53:184–94.
Boparai KS, Dekker E, Van Eeden S, et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology. 2008;135:2014–18.
Leggett BA, Devereaux B, Biden K, et al. Hyperplastic polyposis. Am J Surg Pathol. 2001;25:177–84.
Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006;101:385–98.
Lynch HT, Boland CR, Gong G, et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet. 2006;14:390–402.
Strate LL, Syngal S. Hereditary colorectal cancer syndromes. Cancer Causes Control. 2005;16:201–13.
Lubbe SJ, Di Bernardo MC, Chandler IP, et al. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol. 2009;27:3975–80.
Lipton L, Halford SE, Johnson V, et al. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res. 2003;63:7595–9.
Vasen HFA. Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer. 2005;4:219–25.
Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–32.
Cao Y, Pieretti M, Marshall J, et al. Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature. Am J Gastroenterol. 2002;97:1822–7.
Mecklin J-P, Aarino M, Läärä E, et al. Development of colorectal tumours in colonoscopic surveillance in Lynch syndrome. Gastroenterology. 2007;133:1093–8.
Knudsen AL, Bisgaard ML, Bülow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer. 2003;2:43–55.
Olschwang S, Blanché H, de Moncuit C, et al. Similar colorectal cancer risk in patients with monoallelic and biallelic mutations in the MYH gene identified in a population with adenomatous polyposis. Genet Test. 2007;11:315–20.
Kumar VKA, Gold JA, Mallon E, et al. Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin. Fam Cancer. 2008;7(2):187–9. doi:10.1007/s10689-007-9161-9.
Barnetson RA, Devlin L, Miller J, et al. Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer. Clin Genet. 2007;72:551–5.
Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30.
Cancer Research UK. http://www.cancerresearchuk.org/.
Burns T, Breathnach S, Cox N, et al. Rook’s textbook of dermatology. 7th ed. Chapter 37 Tumours of the skin appendages & Chapter 43 Disorders of the sebaceous glands. USA: Blackwell Science; 2004.
Tenesa A, Campbell H, Barnetson R, et al. Association of MUTYH and colorectal cancer. Br J Cancer. 2006;95:239–42.
Parker AR, Sieber OM, Shi C, et al. Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair. Carcinogenesis. 2005;26:2010–8.
Raoof M, Canter RJ, Paty PB. Variable phenotypic expression of identical MYH germline mutations in siblings with attenuated familial adenomatous polyposis. Am Surg. 2007;73:1250–3.
Crabtree MD, Tomlinson IPM, Hodgson SV, et al. Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes. Gut. 2002;51:420–3.
Zhou XL, Djureinovic T, Werelius B, et al. Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. Genet Test. 2005;9:147–51.
Jones N, Vogt S, Nielsen M, et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology. 2009;137:489–94.
Butterworth AS, Higgins JPT, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42:216–27.
Vasen HFA, Möslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut. 2008;57:704–13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jones, N. et al. (2010). MUTYH-Associated Polyposis. In: Rodriguez-Bigas, M., Cutait, R., Lynch, P., Tomlinson, I., Vasen, H. (eds) Hereditary Colorectal Cancer. M.D. Anderson Solid Tumor Oncology Series, vol 5. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-6603-2_19
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6603-2_19
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-6602-5
Online ISBN: 978-1-4419-6603-2
eBook Packages: MedicineMedicine (R0)